[1]
“Serum gp91phox/NOX2 Level Among Patients with Subclinical Hypothyroidism, and Its Relation to Atherogenic Indices”, Adv.med.j., vol. 10, no. 2, pp. 118–125, Jun. 2025, doi: 10.56056/amj.2025.350.